VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 42 filers reported holding VIRACTA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76,960 | -56.3% | 74,000 | -40.8% | 0.00% | -50.0% |
| Q2 2023 | $176,250 | -11.3% | 125,000 | 0.0% | 0.00% | -20.0% |
| Q1 2023 | $198,750 | +8.9% | 125,000 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $182,500 | -55.0% | 125,000 | +31.6% | 0.01% | -54.5% |
| Q3 2022 | $406,000 | +49.3% | 95,000 | +35.7% | 0.01% | +83.3% |
| Q2 2022 | $272,000 | -18.3% | 70,000 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $333,000 | +160.2% | 70,000 | +100.0% | 0.01% | +200.0% |
| Q4 2021 | $128,000 | -68.1% | 35,000 | -30.0% | 0.00% | -75.0% |
| Q3 2021 | $401,000 | -29.3% | 50,000 | 0.0% | 0.01% | -20.0% |
| Q2 2021 | $567,000 | – | 50,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 689,709 | $717,297 | 0.22% |
| Aisling Capital Management LP | 288,571 | $300,114 | 0.12% |
| BVF INC/IL | 3,614,662 | $3,759,248 | 0.10% |
| TRUST CO OF TOLEDO NA /OH/ | 33,213 | $34,542 | 0.01% |
| MAI Capital Management | 397,670 | $413,577 | 0.01% |
| Laurion Capital Management LP | 698,000 | $725,920 | 0.00% |
| RP Management, LLC | 3,700 | $3,848 | 0.00% |
| UNITED BANK | 20,000 | $20,800 | 0.00% |
| BOURGEON CAPITAL MANAGEMENT LLC | 7,500 | $7,800 | 0.00% |
| XTX Topco Ltd | 12,084 | $12,567 | 0.00% |